This post is from a suggested group

Incretin Mimetics Market Size
The global incretin mimetics market size was valued at USD 14.15 billion in 2024 and is expected to reach USD 31.90 billion by 2032, at a CAGR of 10.69% during the forecast period
The market growth is largely fueled by the rising prevalence of type 2 diabetes globally, alongside an increasing focus on innovative therapies that offer better glycemic control with reduced side effects. Incretin mimetics, such as GLP-1 receptor agonists, are gaining traction due to their dual benefit of glucose regulation and weight management
𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -

